Godavari Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
73.07
-2.28 (-3.03%)
BSENSE

Dec 05

BSE+NSE Vol: 4.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Phaarmasia
Checkpoint Trend
Murae Organisor
Biofil Chemicals
Vasundhara Rasy.
Vivo Bio Tech
Godavari Drugs
Lasa Supergeneri
Vista Pharma.
Shelter Pharma
Bacil Pharma
Why is Godavari Drugs Ltd ?
1
Weak Long Term Fundamental Strength with a -0.27% CAGR growth in Net Sales over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.27 times
2
The company has declared Negative results for the last 4 consecutive quarters
  • PAT(9M) At Rs 2.93 cr has Grown at -45.83%
  • OPERATING CF(Y) Lowest at Rs 11.20 Cr
  • NET SALES(9M) At Rs 75.96 cr has Grown at -21.64%
3
Below par performance in long term as well as near term
  • Along with generating -40.86% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Godavari Drugs for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Godavari Drugs
-40.86%
-0.92
44.25%
Sensex
4.83%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-0.27%
EBIT Growth (5y)
3.90%
EBIT to Interest (avg)
2.39
Debt to EBITDA (avg)
3.62
Net Debt to Equity (avg)
1.37
Sales to Capital Employed (avg)
2.09
Tax Ratio
22.59%
Dividend Payout Ratio
0
Pledged Shares
0.22%
Institutional Holding
0.50%
ROCE (avg)
13.39%
ROE (avg)
13.97%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
34
Price to Book Value
1.27
EV to EBIT
14.20
EV to EBITDA
10.82
EV to Capital Employed
1.11
EV to Sales
1.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.13%
ROE (Latest)
8.54%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-10What is not working for the Company
PAT(9M)

At Rs 2.93 cr has Grown at -45.83%

OPERATING CF(Y)

Lowest at Rs 11.20 Cr

NET SALES(9M)

At Rs 75.96 cr has Grown at -21.64%

PBDIT(Q)

Lowest at Rs 1.99 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 7.47%

PBT LESS OI(Q)

Lowest at Rs 0.48 cr.

Loading Valuation Snapshot...
Here's what is not working for Godavari Drugs
Profit After Tax (PAT) - Nine Monthly
At Rs 2.93 cr has Grown at -45.83%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Nine Monthly
At Rs 75.96 cr has Grown at -21.64%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Cash Flow - Annually
Lowest at Rs 11.20 Cr
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 1.99 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 7.47%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.48 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)